Definitive Contract 75N93020C00024
Award Date
7/1/20
Potential Completion Date
12/31/22
Potential Value
$600K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Silver Lake Research Corporation
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Irwindale, CA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
Silver Lake Research Corporation, doing business as Silver Lake Research Corp., has been awarded a firm fixed price definitive contract valued at $600,000 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under this contract, Silver Lake will deliver EAP-derived monoclonal antibodies for immune targets involved in cell activation in hamsters, as requested in the original solicitation. The prime contractor will perform work in Irwindale, California....
This $750,000 Small Business Innovation Research (SBIR) Phase II award was granted by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Silver Lake Research Corporation, doing business as Silver Lake Research Corp, a small business manufacturer of rapid testing innovations. The contract supports the development of reagents for immunologic analysis of non-mammalian and underrepresented mammalian models, as part of an...
The Department of Homeland Security Science and Technology Directorate awarded a firm-fixed-price contract valued at $1,656,989.53 to Silver Lake Research Corporation, a for-profit organization and manufacturer of goods, for the rapid detection of high-priority foreign animal pathogens using enzyme-linked immunosorbent assay (ELISA)-derived hyperspecific monoclonal antibodies. This contract, which does not have a set-aside designation, is for the development of rapid testing innovations,...
This definitive contract from the Department of Health and Human Services' National Institutes of Health and National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) is valued at $600,000 to Qoolabs Inc. for monoclonal antibodies research aligned with SBIR Topic 107. The solicitation sought Small Business Innovation Research (SBIR) proposals across technical topics within NIH Institutes and CDC Centers to develop medical technologies, diagnostics, vaccines, cell therapies and...
This is a $1,500,000.00 Firm Fixed Price definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to Qoolabs Inc., a woman-owned small disadvantaged business located in Carlsbad, California. The contract is for the production of affinity reagents for the immune system of guinea pigs, including interleukins IL1B, IL2, IL4, IL6, IL8, IL10, IL12, and IL13. There was no set-aside used for this award. Qoolabs Inc. has extensive...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Lakepharma, Inc., a minority-owned, for-profit biopharmaceutical contract development and manufacturing organization (CDMO). The $20,000 contract is for the "heavy and light humanization of 1B3 MAB", which involves antibody humanization services to support NIAID's medical research and healthcare mission. The...
<p>The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $7.75 million delivery order contract to Sri International for animal model development and efficacy testing of candidate monoclonal antibodies. The prime contractor, Sri International, will perform this work at its facility located at West Menlo Park, California over a two year period ending September 2029. The contract uses a cost plus fixed fee pricing arrangement.</p>
This is a Cost Plus Fixed Fee contract awarded by the U.S. Department of Homeland Security (DHS) Science and Technology Directorate to Silver Lake Research Corporation, a small business, for research and development services related to the generation, validation, and characterization of new monoclonal antibodies reactive with a group of toxins. The contract has a ceiling value of $1,167,200.00 and an ultimate completion date of December 31, 2019. This award does not have a set-aside designation....
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $540,608 firm fixed price definitive contract to Abterra Biosciences, Inc., doing business as Digital Proteomics, as part of the Small Business Innovation Research Program Phase I solicitation. Under the contract, Digital Proteomics will deliver comprehensive reagents for immunophenotyping rabbit cell-mediated immunity to support research related to...
This $596,519 fixed-price federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Ampersand Biosciences LLC, a woman-owned small business. The contract is for the development of reagents to support immunologic analysis of non-mammalian and underrepresented mammalian models, such as ferrets and mice, under SBIR Topic 107. This aligns with NIAID's mission to conduct and support research to...